GLP-1 journey background

Your GLP-1 Journey Companion

Expert nutrition guidance, protein-rich recipes, and practical tips for people taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro.

Why The GLPSpot?

Protein-Forward Recipes

Meals designed to meet your protein goals even when appetite is reduced.

Portion Guidance

Smart serving sizes that work with your changing relationship with food.

Community Support

Tips and insights from real people on their GLP-1 journey.

GLP-1 Essentials

The products people on GLP-1 medications reach for most — hydration, protein, gut support, and nausea relief.

As an Amazon Associate I earn from qualifying purchases.

Ultima Replenisher Electrolyte Powder (Variety Pack)

Zero-sugar electrolyte stickpacks with a variety of flavors — easy to keep in a bag for low-appetite days.

Premier Protein Shakes (Ready-to-Drink)

Ready-to-drink protein can be clutch on low-appetite days when cooking sounds impossible.

BelliWelli Fiber Supplement

Top Pick

A simple daily fiber option to support gut comfort and regularity.

Gin Gins Original Ginger Chews (1 lb bag)

Ginger chews are a common go-to for mild nausea — easy to keep in a bag.

Magnesium Glycinate

Often chosen for general magnesium support; some people find magnesium helps with bowel regularity too.

BlenderBottle Shaker Bottle

Makes it easier to actually use protein powder without a blender.

Real-World, No-Shame Help

The goal is simple: keep you nourished, hydrated, and feeling good—without fighting your new appetite.

I stopped forcing huge meals and started focusing on protein first. My energy came back fast.

Protein-first approach

The grocery list idea was a game-changer. I finally had 'easy options' for low-appetite days.

Simpler shopping

The hydration reminders + electrolytes tips saved me. I didn't realize how much that affected nausea.

Hydration wins

Latest Articles

View All
Foundayo vs Zepbound: Pill vs Injection, Results, Cost, and Who Each Fits
MedicationsMay 30, 20268 min read

Foundayo vs Zepbound: Pill vs Injection, Results, Cost, and Who Each Fits

Foundayo is a daily GLP-1 pill. Zepbound is a weekly GIP/GLP-1 injection. No head-to-head trial exists. Here is how they compare on weight loss, side effects, cost, convenience, and who each fits best.

Read Foundayo vs Zepbound: Pill vs Injection, Results, Cost, and Who Each Fits
Tirzepatide Gum: Real GLP-1 or Scam?
GLP-1 Scams & SafetyMay 15, 20266 min read

Tirzepatide Gum: Real GLP-1 or Scam?

No FDA-approved tirzepatide gum exists. Here's why GLP-1 peptides can't work in gum form — and what actually works instead.

Read Tirzepatide Gum: Real GLP-1 or Scam?
Bimagrumab: Can It Fix Muscle Loss on Ozempic?
MedicationsMay 10, 20268 min read

Bimagrumab: Can It Fix Muscle Loss on Ozempic?

Bimagrumab is an experimental drug from Novartis that blocks a pathway limiting muscle growth. Early trials pairing it with semaglutide show better fat loss and muscle preservation than GLP-1s alone.

Read Bimagrumab: Can It Fix Muscle Loss on Ozempic?
Zepbound Pill: Oral Tirzepatide for Weight Loss (What We Know)
MedicationsMay 8, 20266 min read

Zepbound Pill: Oral Tirzepatide for Weight Loss (What We Know)

Eli Lilly is developing an oral version of tirzepatide (Zepbound). Phase 3 trials are underway. Here's what we know and how it compares to Foundayo and other oral options.

Read Zepbound Pill: Oral Tirzepatide for Weight Loss (What We Know)
Amycretin vs Ozempic: What We Know So Far
MedicationsMay 6, 20267 min read

Amycretin vs Ozempic: What We Know So Far

Amycretin is an experimental weight loss pill from Novo Nordisk that targets both GLP-1 and amylin receptors. Phase 2 trials are now underway. Here's how it compares to Ozempic.

Read Amycretin vs Ozempic: What We Know So Far

Starting Your GLP-1 Journey?

Get practical nutrition advice delivered to your inbox. No spam, just helpful tips for your success.

Want More GLP-1 Nutrition Tips?

Get weekly recipes and nutrition advice delivered straight to your inbox. No spam, ever.

We respect your privacy. Unsubscribe anytime.